Sam Tomlinson, Vice President of Global Drug Safety at Arriello unpacks North America/EU research which compares today’s commercialisation strategies with those of five years ago.   As biotechs around the world look to new territories including emerging markets for their next returns, many are encountering unexpected hurdles. Too often, there is a significant gap between the envisaged […]